Borghaei, H., & Steins, M. (2015). Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. The New England journal of medicine, 373(17), . https://doi.org/10.1056/NEJMoa1507643
Chicago Style (17th ed.) CitationBorghaei, Hossein, and Martin Steins. "Nivolumab Versus Docetaxel in Advanced Nonsquamous Non-small-cell Lung Cancer." The New England Journal of Medicine 373, no. 17 (2015). https://doi.org/10.1056/NEJMoa1507643.
MLA (9th ed.) CitationBorghaei, Hossein, and Martin Steins. "Nivolumab Versus Docetaxel in Advanced Nonsquamous Non-small-cell Lung Cancer." The New England Journal of Medicine, vol. 373, no. 17, 2015, https://doi.org/10.1056/NEJMoa1507643.
Warning: These citations may not always be 100% accurate.